Biopharma
Regeneron Pharmaceuticals
Regeneron combines proprietary antibody and genetics platforms to discover medicines in immunology, oncology, and ophthalmology. Its Regeneron Genetics Center has sequenced millions of exomes, fueling target discovery across its pipeline.
$4.4B R&D Spend
Biopharma Industry
310 Academic Collaborations
3,500 Patents
Free to browse · subscribe to unlock the full dataset
See the full dataset.
Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.
Sign Up Free →